CADRE BIOSCIENCE, LLC

Saint Louis, MO · Biotech · Private

Small molecule inhibitors of acetyl CoA synthetase 2 (ACSS2) for cancer treatment

Grants
$784K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Estrogen-related receptor agonists for the treatment of heart failure.$430,855
Federal grantDepartment of Health and Human Services · Phase I · Development of a Novel Approach to Immunotherapy.$353,411
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1314THERATARGET, INC.——
1315OAKGROVE BIO LLC——
1316MEDVAS CONCEPTS, LLC——
1317CADRE BIOSCIENCE, LLC——
1318BOTANISOL, LLC——
1319ONCA BIO, INC.——
1320OASIS PHARMACEUTICALS, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.